アジェンダ
9:00 AM — 10:00 AM
10:00 AM — 10:10 AM
Opening Remarks10:10 AM — 10:40 AM
Keynote Speech10:40 AM — 10:55 AM
Brexit Consideration of HMA and Paul-Ehrlich-Institut10:55 AM — 11:40 AM
Session 1: Manufacturing and Supply – Ensuring Patients’ Access11:40 AM — 12:25 PM
Session 2: Clinical Trials – From Directive to Regulation12:25 PM — 1:25 PM
1:25 PM — 2:30 PM
Session 3: Regulatory Planning – Preparing for Day 12:30 PM — 3:15 PM
Panel Discussion with Q&A3:15 PM — 3:45 PM
4:15 PM — 5:05 PM
Session 5: Brexit Time Check: What’s Next for Medicines?5:05 PM — 5:15 PM
Closing Remarks